Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRA | P25101 | 18/20 | 0.64 |
| ▸ | EDNRB | P24530 | 17/20 | 0.64 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.44 |
| ▸ | TSPO | P30536 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14380566 | 1.00 | EDNRA (0.64) | EDNRAEDNRBSLC6A2TSPODRD3 | |
| SCHEMBL14380571 | 0.92 | EDNRB (0.58) | EDNRAEDNRBCA12CA2CA7 | |
| SCHEMBL5631309 | 0.91 | EDNRA (0.63) | EDNRAEDNRBCA12CA2CA7 | |
| SCHEMBL14380562 | 0.89 | EDNRA (0.61) | EDNRAEDNRBCA12CA2CA7 | |
| SCHEMBL14380560 | 0.88 | EDNRA (0.62) | EDNRAEDNRBCA12CA2CA7 | |
| SCHEMBL14380618 | 0.83 | EDNRA (0.62) | EDNRAEDNRBSLC6A2TSPODRD3 | |
| SCHEMBL1001936 | 0.83 | EDNRA (0.51) | EDNRAEDNRBSLC6A2TSPODRD3 | |
| SCHEMBL9891391 | 0.82 | EDNRB (0.79) | EDNRAEDNRBSLC6A2TSPODRD3 | |
| SCHEMBL16371661 | 0.81 | EDNRA (0.63) | EDNRAEDNRBSLC6A2TSPODRD3 | |
| SCHEMBL9891392 | 0.79 | EDNRA (1.00) | EDNRAEDNRBSLC6A2TSPODRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504609-A | Alpraxitans an intermediate compound of (C) Alpraxitans and preparation method thereof | 成都启晟合研医药科技有限公司 | 2025-02-25 | — | — | CN | disclosed |